L169I (p.Leu169Ile) variant of CYP51A1 (Lanosterol 14-alpha demethylase)
L169I (p.Leu169Ile) in CYP51A1 (Lanosterol 14-alpha demethylase) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
L169I (p.Leu169Ile) variant details
- p.Leu169Ile
- NCI-TCGA Cosmic COSV9913
- cosmic curated COSV99133
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available